Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11951174 Therapeutics directed against coronavirus

Overview Structured Data Issues Contributors Activity

Is a

0

Date Filed

April 17, 2023

0

Date of Patent

April 9, 2024

0

Patent Application Number

18301761

0

Patent Citations

US Patent 9884895 Methods and compositions for chimeric coronavirus spike proteins

0

US Patent 10443049 Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2)

0

US Patent 7396914 SARS nucleic acids, proteins, antibodies, and uses thereof

0

US Patent 7491397 Receptor binding polypeptides

0

US Patent 7527967 Recombinant baculovirus and virus-like particle

0

US Patent 7888102 Cell line for producing coronaviruses

0

US Patent 8080642 Severe acute respiratory syndrome DNA compositions and methods of use

0

US Patent 8241864 Method for determining ACE2 activity

0

US Patent 8541003 Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using

0

US Patent 8586319 Recombinant ACE2 polypeptide dimer

0

Patent Inventor Names

Sunanda Singh

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

0

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

Find more entities like US Patent 11951174 Therapeutics directed against coronavirus

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool